Related content

Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis

By Verrips A.  

Brain, Vol. 123, Iss. 5, 2000-05 ,pp. : 908-919

Oxford University Press

Access to resources Recommend Favorite

Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis

By Verrips A.   Lycklama à Nijeholt G. J.   Barkhof F.   Van Engelen B. G. M.   Wesseling P.   Luyten J. A. F. M.   Wevers R. A.   Stam J.   Wokke J. H. J.   van den Heuvel L. P. W. J.   Keyser A.  

Brain, Vol. 122, Iss. 8, 1999-08 ,pp. : 1589-1595

Oxford University Press

Access to resources Recommend Favorite

Spinal phenotype of cerebrotendinous xanthomatosis

By Bartholdi D.   Zumsteg D.   Verrips A.   Wevers R.   Sistermans E.   Hess K.   Jung H.  

Journal of Neurology, Vol. 251, Iss. 1, 2004-01 ,pp. : 105-107

Springer Publishing Company

Access to resources Recommend Favorite

Botulinum toxin treatment of spasticity: A clinical and neurophysiological study

By Cassetta E.   Pauri F.   Fusco E.   Rossini P.M.  

Electroencephalography and Clinical Neurophysiology, Vol. 103, Iss. 1, 1997-07 ,pp. : 171-172

Elsevier

Access to resources Recommend Favorite

Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene

By Gallus G.   Dotti M.   Federico A.  

Neurological Sciences, Vol. 27, Iss. 2, 2006-06 ,pp. : 143-149

Springer Publishing Company

Access to resources Recommend Favorite